Table 1.
Challenges of ncRNA delivery
| Problem | Reason | Solution | References |
|---|---|---|---|
| Chemical instability characteristics of ncRNA | Physical and chemical properties Easily degraded by endogenous nuclease |
Chemical or structural modification | Lee et al.; Sarett et al.; Whitehead et al.; Alexis et al.; Broderick et al.; Wilson et al.; Kooi et al.; Hacein-Bey-Abina69, 70, 71, 72, 73, 74, 75, 76 |
| Extracellular and intracellular barriers | Irregular and heterogeneously high permeability of vascular tissue ncRNAs are susceptible to phagocytosis by late endosomes |
Specifically targeting the vascular system and increasing the solubility of drugs Neutrally charged ionizable lipids can be used to induce lysosomal rupture, releasing ncRNAs |
Wang et al.; Danquah et al.; Akhtar et al.; Semble et al.77, 78, 79, 80 |
| The hurdle of immunogenicity | RNA interference, NF-κB activation, and pro-inflammatory cytokine production Type I interferon response |
Third-generation modifications, such as PMOs | Winkle et al.; Barton et al.; Fabbri et al.; Cirak et al.; Sledz et al.17,81, 82, 83, 84) |
| Off-target effects | Induction of interferon response Partial complementarity of nucleic acid and unexpected targets |
Specific targeted receptor ligand | Hanagata et al.; Jackson et al.; Juliano and Carver85, 86, 87) |